These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32706185)

  • 21. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours.
    Lhommée E; Klinger H; Thobois S; Schmitt E; Ardouin C; Bichon A; Kistner A; Fraix V; Xie J; Aya Kombo M; Chabardès S; Seigneuret E; Benabid AL; Mertens P; Polo G; Carnicella S; Quesada JL; Bosson JL; Broussolle E; Pollak P; Krack P
    Brain; 2012 May; 135(Pt 5):1463-77. PubMed ID: 22508959
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of brain serotonin subtype 1B receptors in levodopa-induced motor complications.
    Morin N; Morissette M; Grégoire L; Rajput A; Rajput AH; Di Paolo T
    Neuropharmacology; 2015 Dec; 99():356-68. PubMed ID: 26254863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Jejunal levodopa infusion in long-term DBS patients with Parkinson's disease.
    Klostermann F; Jugel C; Marzinzik F
    Mov Disord; 2011 Oct; 26(12):2298-9. PubMed ID: 21714008
    [No Abstract]   [Full Text] [Related]  

  • 24. Spatial memory improvement by levodopa in parkinsonian MPTP-treated monkeys.
    Fernández-Ruiz J; Doudet D; Aigner TG
    Psychopharmacology (Berl); 1999 Nov; 147(1):104-7. PubMed ID: 10591875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of DBS, premotor rTMS, and levodopa on motor function and silent period in advanced Parkinson's disease.
    Bäumer T; Hidding U; Hamel W; Buhmann C; Moll CK; Gerloff C; Orth M; Siebner HR; Münchau A
    Mov Disord; 2009 Apr; 24(5):672-6. PubMed ID: 19185021
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of subthalamic nucleus deep brain stimulation on balance in Parkinson's disease: A static posturographic analysis.
    De la Casa-Fages B; Alonso-Frech F; Grandas F
    Gait Posture; 2017 Feb; 52():374-380. PubMed ID: 28061431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct inhibition of levodopa-induced beginning-of-dose motor deterioration by subthalamic nucleus stimulation in a patient with Parkinson disease.
    Oshima H; Katayama Y; Fukaya C; Kano T; Kobayashi K; Yamamoto T; Suzuki Y
    J Neurosurg; 2008 Jan; 108(1):160-3. PubMed ID: 18173326
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EuroInf 2: Subthalamic stimulation, apomorphine, and levodopa infusion in Parkinson's disease.
    Dafsari HS; Martinez-Martin P; Rizos A; Trost M; Dos Santos Ghilardi MG; Reddy P; Sauerbier A; Petry-Schmelzer JN; Kramberger M; Borgemeester RWK; Barbe MT; Ashkan K; Silverdale M; Evans J; Odin P; Fonoff ET; Fink GR; Henriksen T; Ebersbach G; Pirtošek Z; Visser-Vandewalle V; Antonini A; Timmermann L; Ray Chaudhuri K;
    Mov Disord; 2019 Mar; 34(3):353-365. PubMed ID: 30719763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and neuropsychological follow up at 12 months in patients with complicated Parkinson's disease treated with subcutaneous apomorphine infusion or deep brain stimulation of the subthalamic nucleus.
    De Gaspari D; Siri C; Landi A; Cilia R; Bonetti A; Natuzzi F; Morgante L; Mariani CB; Sganzerla E; Pezzoli G; Antonini A
    J Neurol Neurosurg Psychiatry; 2006 Apr; 77(4):450-3. PubMed ID: 16543520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meta-analysis comparing deep brain stimulation of the globus pallidus and subthalamic nucleus to treat advanced Parkinson disease.
    Liu Y; Li W; Tan C; Liu X; Wang X; Gui Y; Qin L; Deng F; Hu C; Chen L
    J Neurosurg; 2014 Sep; 121(3):709-18. PubMed ID: 24905564
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
    Funkiewiez A; Ardouin C; Krack P; Fraix V; Van Blercom N; Xie J; Moro E; Benabid AL; Pollak P
    Mov Disord; 2003 May; 18(5):524-30. PubMed ID: 12722166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Syndrome dopamine dysregulation and deep brain stimulation of the subthalamic nucleus in Parkinson's disease].
    Omarova SM; Fedorova NV; Tomskiy AA; Gamaleya AA; Bril' EV; Gubareva NN; Poddubskaya AA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12):27-32. PubMed ID: 29376980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Motor features and response to oral levodopa in patients with Parkinson's disease under continuous dopaminergic infusion or deep brain stimulation.
    Elia AE; Dollenz C; Soliveri P; Albanese A
    Eur J Neurol; 2012 Jan; 19(1):76-83. PubMed ID: 21645174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alleviation of experimental hemiparkinsonism by high-frequency stimulation of the subthalamic nucleus in primates: a comparison with L-Dopa treatment.
    Benazzouz A; Boraud T; Féger J; Burbaud P; Bioulac B; Gross C
    Mov Disord; 1996 Nov; 11(6):627-32. PubMed ID: 8914087
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonmotor symptoms evolution during 24 months of bilateral subthalamic stimulation in Parkinson's disease.
    Dafsari HS; Silverdale M; Strack M; Rizos A; Ashkan K; Mahlstedt P; Sachse L; Steffen J; Dembek TA; Visser-Vandewalle V; Evans J; Antonini A; Martinez-Martin P; Ray-Chaudhuri K; Timmermann L;
    Mov Disord; 2018 Mar; 33(3):421-430. PubMed ID: 29465787
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sedation with α2 Agonist Dexmedetomidine During Unilateral Subthalamic Nucleus Deep Brain Stimulation: A Preliminary Report.
    Morace R; De Angelis M; Aglialoro E; Maucione G; Cavallo L; Solari D; Modugno N; Santilli M; Esposito V; Aloj F
    World Neurosurg; 2016 May; 89():320-8. PubMed ID: 26805677
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MPTP Induces Systemic Parkinsonism in Middle-Aged Cynomolgus Monkeys: Clinical Evolution and Outcomes.
    Yue F; Zeng S; Tang R; Tao G; Chan P
    Neurosci Bull; 2017 Feb; 33(1):17-27. PubMed ID: 27699717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response to levodopa in parkinsonian patients with bilateral subthalamic nucleus stimulation.
    Moro E; Esselink RJ; Benabid AL; Pollak P
    Brain; 2002 Nov; 125(Pt 11):2408-17. PubMed ID: 12390968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of L-Dopa on metabotropic glutamate receptor 5 in the brain of parkinsonian monkeys.
    Ouattara B; Gasparini F; Morissette M; Grégoire L; Samadi P; Gomez-Mancilla B; Di Paolo T
    J Neurochem; 2010 May; 113(3):715-24. PubMed ID: 20132464
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson's disease 4 years after surgery: double blind and open label evaluation.
    Rodriguez-Oroz MC; Zamarbide I; Guridi J; Palmero MR; Obeso JA
    J Neurol Neurosurg Psychiatry; 2004 Oct; 75(10):1382-5. PubMed ID: 15377681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.